Compass Pathways and DBSA Survey Exposes the Significant Impact of Treatment-Resistant Depression on Patients, Families and Caregivers
Compass Pathways, a biotechnology company focused on developing urgently needed treatment options for mental health conditions, has partnered with the Depression and Bipolar Support Alliance (DBSA) to highlight the significant challenges faced by people living with treatment-resistant depression (TRD). The two organizations have released a new report based on a national survey examining the experiences of patients with TRD and the caregivers who support them.
The survey provides insight into the physical, emotional, social and financial challenges associated with treatment-resistant depression. It includes responses from 261 people living with TRD and 73 caregivers, offering a closer look at how prolonged depressive episodes and unsuccessful treatment experiences can affect everyday life.
The findings reveal that treatment-resistant depression can extend far beyond symptoms of depression. For many patients, the condition affects their ability to maintain relationships, pursue professional opportunities, participate in important life events and maintain hope for the future. Caregivers and family members also experience considerable challenges as they provide ongoing support to loved ones.
According to the report, many individuals living with TRD have spent years trying different treatment approaches without achieving meaningful improvement. Repeated treatment attempts can create emotional exhaustion and leave patients feeling frustrated, isolated and uncertain about whether they will experience lasting relief.
The survey also highlights the importance of recognizing treatment-resistant depression earlier, improving access to support services and encouraging discussions between patients and healthcare professionals about alternative treatment approaches when existing therapies are not delivering the expected results.
Survey Highlights the Everyday Reality of Treatment-Resistant Depression
Treatment-resistant depression is a form of major depressive disorder in which patients do not experience an adequate response to multiple treatment attempts. People living with the condition may continue experiencing significant depressive symptoms despite receiving different therapies.
The challenges associated with TRD can be particularly difficult because patients may spend extended periods navigating treatment options while continuing to experience symptoms that interfere with their personal and professional lives.
The joint survey conducted by Compass Pathways and DBSA explores these experiences from the perspectives of both patients and caregivers.
One of the most significant findings is that 95% of surveyed patients described themselves as functioning but struggling, surviving day-to-day or barely getting by. This suggests that even when individuals continue participating in some everyday activities, they may still be experiencing substantial emotional and psychological difficulties.
More than 70% of respondents said their condition had left them feeling hopeless about their future.
These findings demonstrate how prolonged depressive episodes can affect an individual’s outlook, confidence and ability to imagine a meaningful improvement in their circumstances.
For many people, the challenges are not limited to managing symptoms. Living with TRD can also mean repeatedly adjusting personal expectations, postponing important decisions and struggling to maintain relationships and professional responsibilities.
The report brings attention to these experiences and highlights the importance of considering the broader impact of depression when evaluating treatment needs.
Repeated Treatment Attempts Create Emotional Exhaustion
Another major theme identified in the survey is the emotional burden associated with trying multiple treatments without achieving meaningful relief.Almost 75% of surveyed patients said they felt they had already tried all available treatment options. Many also reported feeling emotionally exhausted after experiencing repeated unsuccessful treatment attempts.
For patients living with persistent depressive symptoms, treatment can become a lengthy process involving different medications, adjustments and other therapeutic approaches.Although treatment plans are intended to help individuals manage their condition, the experience of trying multiple options without meaningful improvement can create additional emotional challenges.
Patients may begin to question whether another treatment will work or whether their condition will ever improve.
The survey also found that more than 60% of patients wished they had been able to explore different treatment approaches sooner after recognizing that their existing treatment was not working.This finding highlights the importance of ongoing conversations between patients and healthcare professionals about treatment effectiveness.
Regular evaluation can help clinicians understand whether patients are experiencing meaningful improvement and determine whether adjustments or alternative approaches should be considered.For individuals with treatment-resistant depression, timely discussions about additional treatment options may be particularly important because prolonged periods without adequate relief can further affect quality of life.
The findings also point to the need for continued research and development of new treatment approaches for people who have not responded adequately to existing therapies.
Patients Report Feeling Blamed and Misunderstood
The emotional experience of living with treatment-resistant depression is another important area addressed in the report.More than half of surveyed patients said one of the most difficult aspects of their condition was feeling as though they were the problem rather than the medication or treatment approach.
This finding highlights the self-blame and stigma that can accompany prolonged depression.When patients continue experiencing symptoms despite receiving treatment, they may begin to believe that their lack of improvement reflects a personal failure.
However, treatment resistance is a complex clinical challenge, and an inadequate response to treatment should not be interpreted as a lack of effort or commitment from the patient.The survey found that nearly nine out of 10 respondents had experienced judgment or misunderstanding because their depression had not improved.
Nearly half also reported that they often or always blamed themselves for not getting better with treatment.These experiences can make it more difficult for patients to discuss their condition openly or seek additional support.
The findings emphasize the importance of communication between patients, caregivers and healthcare professionals. A supportive healthcare environment can help individuals feel understood and encourage them to discuss treatment challenges without fear of judgment.
Reducing the stigma associated with treatment-resistant depression is also important for improving awareness and helping patients recognize that continued symptoms are not their fault.By documenting these experiences, Compass Pathways and DBSA aim to bring greater attention to the challenges that patients often face outside clinical settings.
Treatment-Resistant Depression Affects Relationships and Career Opportunities
The impact of TRD can extend into nearly every part of an individual’s personal and professional life.According to the survey, more than half of respondents said treatment-resistant depression had robbed them of years of their lives.Patients described missing important milestones, losing career opportunities and experiencing strained relationships as a result of their condition.
The findings show that 69% of surveyed patients reported a negative impact on their friendships, while 50% said their marriages or partnerships had been affected.Maintaining relationships can become challenging when individuals experience prolonged depressive symptoms. Patients may find it difficult to participate in social activities, communicate with loved ones or maintain the level of engagement they previously had with friends and family.
Over time, these challenges can contribute to isolation and affect the quality of personal relationships.The workplace is another area where the condition can create significant difficulties.More than half of surveyed patients reported reducing their working hours because of TRD. Additionally, more than one-third said they had resigned from a job.
These findings demonstrate the potential economic consequences of treatment-resistant depression.When symptoms interfere with concentration, motivation, energy and daily functioning, maintaining regular employment can become increasingly difficult.Reduced working hours or leaving employment can also create financial uncertainty, particularly for individuals who require ongoing healthcare services and treatment.
The loss of professional opportunities may further affect confidence and personal identity, creating additional challenges for people already managing prolonged depressive symptoms.The survey therefore highlights the importance of understanding TRD as a condition that can influence not only mental health but also economic stability, social participation and long-term personal development.
Caregivers and Families Experience Significant Emotional Burdens
The report also examines the impact of treatment-resistant depression on caregivers and family members.While patients experience the direct effects of the condition, caregivers often take on additional responsibilities to provide emotional, practical and sometimes financial support.
Approximately 70% of surveyed caregivers said TRD affects the social, physical or mental health of the entire family.More than half reported that caregiving had taken a major toll on their own mental health.These findings demonstrate that the effects of treatment-resistant depression can extend beyond the individual receiving treatment.
Family members may need to adjust their schedules, change personal plans and devote considerable time and energy to supporting someone living with persistent depressive symptoms.Caregiving responsibilities can also affect relationships within the household and reduce opportunities for social activities.
The report highlights how emotional exhaustion can increase as the duration of a loved one’s condition continues.Approximately half of caregivers reported experiencing emotional exhaustion within three years of their loved one’s TRD diagnosis.
Among caregivers supporting individuals who had been diagnosed for three or more years, the figure increased significantly, with 95% reporting emotional exhaustion.
The vast majority of these caregivers said they felt emotionally exhausted most or all of the time.This finding points to the cumulative nature of caregiving responsibilities.When a loved one continues experiencing depression without meaningful improvement, caregivers may face prolonged uncertainty and emotional pressure.
They may also struggle to balance caregiving with their own employment, family responsibilities and personal well-being.The findings suggest that caregiver support should be considered an important part of the broader response to treatment-resistant depression.Providing resources, education and appropriate support services for caregivers may help reduce some of the challenges associated with long-term caregiving.
DBSA Calls for Greater Awareness and Earlier Treatment Discussions
Suzanne Baber, LCSW, Chief Executive Officer of the Depression and Bipolar Support Alliance, emphasized that the survey provides an important opportunity to highlight experiences that are often overlooked or misunderstood.
“These results give voice to the realities faced by people living with TRD and the caregivers who support them – experiences that too often go unseen or misunderstood,” Baber said.
She also highlighted the need to improve access to support and encourage clinicians to evaluate alternative treatment options earlier when patients are not responding adequately to their current care.
According to Baber, bringing these experiences into public discussion can help build greater understanding of treatment-resistant depression and encourage meaningful changes in how patients and caregivers are supported.
DBSA’s involvement in the initiative reflects the importance of incorporating patient and caregiver perspectives into conversations about mental health treatment.
Clinical outcomes remain important when evaluating treatment effectiveness, but understanding the daily experiences of people living with TRD can provide additional insight into the challenges that may not always be captured through clinical assessments.
The survey findings reinforce the need for a more comprehensive approach that recognizes the effects of depression on relationships, employment, family life and personal well-being.
Compass Pathways Highlights the Need for New Treatment Options
Compass Pathways also emphasized the importance of listening to patients and caregivers as the company works toward developing new treatment options for mental health conditions.
Steve Levine, MD, Chief Patient Officer at Compass Pathways, said the survey findings demonstrate the extensive impact of treatment-resistant depression on patients and the people supporting them.
“These findings underscore the immense toll treatment-resistant depression can take on nearly every aspect of a person’s life, from their sense of hope and identity to their relationships, careers and ability to participate in the moments that matter,” Levine said.
He also noted that the consequences of TRD extend beyond the individual, with caregivers and families carrying significant emotional, physical and financial responsibilities.
Levine emphasized that these experiences reinforce Compass Pathways’ commitment to listening to and learning from the TRD community.
The company is working to deliver a new treatment option with the potential to help people move beyond simply getting through each day and become more actively engaged in their lives.
The comments reflect the broader need for innovation in mental healthcare, particularly for patients who continue experiencing symptoms despite trying existing treatment approaches.
Developing additional treatment options could provide clinicians with more approaches to consider when working with individuals who have not achieved adequate improvement through their current care plans.
However, treatment decisions must continue to be guided by clinical evidence, individual patient needs and appropriate medical oversight.
Survey Report Provides Additional Insights and Methodology
Compass Pathways and DBSA have made additional information about the survey available through a visual infographic and a detailed report.
The infographic presents a summary of the major findings, including the reported impact of TRD on patients’ daily functioning, relationships, employment and caregivers’ mental health.
The full survey report provides more detailed insights into the experiences of the 261 patients and 73 caregivers who participated in the research, along with information about the survey methodology.
These resources are intended to help healthcare professionals, patients, caregivers and the broader mental health community better understand the challenges associated with treatment-resistant depression.
The findings may also contribute to wider discussions about patient support, treatment access and the need for additional therapeutic approaches.
Bringing Patient and Caregiver Experiences Into Mental Healthcare Discussions
The joint initiative from Compass Pathways and DBSA highlights an important aspect of treatment-resistant depression: its effects are not limited to clinical symptoms.
The survey shows how prolonged depression can influence a person’s sense of identity, relationships, employment, financial circumstances and expectations for the future. It also demonstrates how caregivers and families can experience increasing emotional pressure when supporting someone living with the condition over an extended period.
With 95% of surveyed patients reporting that they were functioning but struggling, surviving day-to-day or barely getting by, the findings underline the importance of looking beyond whether individuals are simply managing their daily responsibilities.
The results also emphasize the need for continued communication between patients and healthcare professionals, timely evaluation of treatment effectiveness, improved access to support and continued development of new treatment options.
For Compass Pathways and DBSA, the survey provides an opportunity to bring the experiences of the TRD community into broader healthcare conversations.
By highlighting the challenges faced by patients and caregivers, the organizations aim to encourage greater awareness, reduce misunderstanding and support efforts to improve the mental healthcare experience.
Ultimately, the findings reinforce the importance of ensuring that people living with treatment-resistant depression are not left to navigate years of unsuccessful treatment attempts without adequate support, understanding or access to appropriate care.
As research and treatment development continue, patient and caregiver experiences will remain important in shaping conversations about the future of mental healthcare and the need for more effective options for individuals living with treatment-resistant depression.
Source link: https://ir.compasspathways.com/
